Irish firm involved in tests of new cervical cancer vaccines

An Irish-based company is joining forces with the National Institutes of Health in Washington to test new vaccines for cervical cancer.

Biotrin International has secured a licence to carry out tests to determine the effectiveness and uptake of the HPV vaccines.